(1)
Harmani Kalim, M. G. F.; Rohman, M. S.; Sargowo, D.; Winarsih, S.; Nugrahenny, D.; Sujuti, H.; Widhaningrum, S. N.; Souhaly, J. . W. Empagliflozin Attenuates Cardiac Fibrosis via Suppression of TLR2/NF-κB Signaling in a Rat Model of Metabolic Syndrome. Trends Sci 2026, 23, 13423.